Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

The involvement of patients in the running of health services was first made a legal requirement in the Health…

The future of the National Health Service came under the spotlight again last week; a report launched by the Health…

Against a backdrop of continued budget restraints, it would be understandable if equipping employees for flexible…

The move to online services has improved the provision of care for residents across Scarborough, opening up the…

Right now, in excess of 150 NHS patients are referred abroad for proton therapy each year. The Department of Health…

British people aren’t saving anywhere near enough, whether it’s for retirement or inevitable rainy…

Six experienced, committed general practitioners talk about retiring early, going abroad, impossible hours, patient…

Promises of a paperless NHS may have been a bold move from Jeremy Hunt, but an approach in Surrey could still…

Healthcare organisations are exploring ways to use wearable devices to simplify, transform and accelerate patient-centric care.

As the journey towards health and social care integration progresses, Colin Henderson explores what lessons can…

The increasing volume of information, data and communications is in danger of drowning public sector employees…

Under constant scrutiny for its public service and spending, the NHS is seeing frequent trailblazing success stories.